Medicare Drug-Related Quality Measures In Development
The Centers for Medicare and Medicaid Services is seeking public comment on draft quality measures to promote better drug adherence, more “appropriate” drug use and better outcomes in the Medicare program.
You may also be interested in...
Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.